130 related articles for article (PubMed ID: 5111743)
1. 5-fluorouracil given once weekly: comparison of intravenous and oral administration.
Bateman JR; Pugh RP; Cassidy FR; Marshall GJ; Irwin LE
Cancer; 1971 Oct; 28(4):907-13. PubMed ID: 5111743
[No Abstract] [Full Text] [Related]
2. 5-Fluorouracil in the treatment of gastrointestinal neoplasia.
Kaufman S
N Engl J Med; 1973 Jan; 288(4):199-201. PubMed ID: 4264581
[No Abstract] [Full Text] [Related]
3. Treatment of cancer with weekly intravenous 5-fluorouracil.
Jacobs EM; Luce JK; Wood DA
Cancer; 1968 Dec; 22(6):1233-8. PubMed ID: 5705785
[No Abstract] [Full Text] [Related]
4. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.
Stolinsky DC; Pugh RP; Bateman JR
Cancer Chemother Rep; 1975; 59(5):1031-3. PubMed ID: 1106846
[No Abstract] [Full Text] [Related]
5. The administration of 5-fluorouracil by mouth.
Bruckner HW; Creasey WA
Cancer; 1974 Jan; 33(1):14-8. PubMed ID: 4810089
[No Abstract] [Full Text] [Related]
6. Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer.
Lokich JJ; Pitman SW; Skarin AT
Oncology; 1975; 32(1):34-7. PubMed ID: 1208028
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
[No Abstract] [Full Text] [Related]
8. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
10. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
[No Abstract] [Full Text] [Related]
11. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
Krauss S; Sonoda T; Solomon A
Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
[No Abstract] [Full Text] [Related]
12. Combined 5-fluorouracil and vinblastine therapy for gastrointestinal and other solid tumors.
al-Sarraf M; Vaughn CB; Reed ML; Vaitkevicious VK
Oncology; 1972; 26(2):99-113. PubMed ID: 5049925
[No Abstract] [Full Text] [Related]
13. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
Tucker WG; Talley RW; Lane M; Bonnet JD
Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
[No Abstract] [Full Text] [Related]
14. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
[TBL] [Abstract][Full Text] [Related]
15. A controlled study of 5-fluorouracil versus 5-fluorouracil and methyl-CCNU in advanced gastrointestinal adenocarcinoma.
Abdallah AM; Soukop M; Bell G; Calman KC
Clin Oncol; 1977 Sep; 3(3):247-57. PubMed ID: 334430
[No Abstract] [Full Text] [Related]
16. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.
Moertel CG; Childs DS; Reitemeier RJ; Colby MY; Holbrook MA
Lancet; 1969 Oct; 2(7626):865-7. PubMed ID: 4186452
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy with cyclophosphamide plus 5-fluorouracil for the treatment of unresectable pancreatic adenocarcinoma.
Chlebowski R; Gota C; Glass A; Weiner J; Bateman JR
Cancer Treat Rep; 1979; 63(11-12):2119-21. PubMed ID: 526947
[No Abstract] [Full Text] [Related]
18. [Oxytetracycline, vehicle for therapeutic drugs, fluorouracil and nitrogen mustard, in the treatment of gastrointestinal tumors].
Gordon B
Hospital (Rio J); 1970 Apr; 77(4):1243-68. PubMed ID: 4939509
[No Abstract] [Full Text] [Related]
19. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
Tormey DC; Gailani S; Leone L
Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
[No Abstract] [Full Text] [Related]
20. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
Hill GJ; Grage TB; Wilson W; Ansfield FJ
J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
